The announcement of an oversubscribed private placement financing is a strong indicator of investor confidence and demand for enGene's shares. This typically leads to a positive market reaction as it reflects both the company's ability to raise significant capital and the high level of interest from investors. Such financial injections are often viewed positively as they can support future growth, R&D, and operational activities without diluting current shareholders' value through public offerings.